B.Riley initiates coverage on BrightSpire Capital (BRSP) with a Buy rating, highlighting its robust cash position and improved credit quality as key drivers for future loan originations, while its stock trades at a discount to book value.
Shares of diversified REIT W. P. Carey have delivered a robust 31% return over the past year, prompting investors to question whether the current price near $69 represents fair value or an opportunity. A closer look reveals a complex picture where traditional metrics and cash flow models tell conflicting stories.
Europe relies on China for the rare earth elements essential in transition technologies, but it's making a late bid to end dependency.
With major indices hovering near record levels and the Federal Reserve on hold, income-focused investors are turning to dividend payers for reliable returns. We analyze three standout stocks offering yields and stability as the market awaits tech earnings season.
From a record-breaking public health crisis in South Carolina to a stunning archaeological find in Mexico, here are the major developments you need to know this afternoon, alongside a look at how global politics is reshaping daily life from Havana to your local coffee shop.
The medical technology giant reported double-digit organic sales growth and robust profitability for 2025, driven by record installations of its Mako surgical robots. While projecting continued strength for 2026, management acknowledged incremental tariff pressures but expressed confidence in the company's ability to sustain margin expansion.
In its Q4 2025 earnings call, SL Green Realty projected strong fundamentals for Manhattan's office market, citing robust leasing and AI-driven demand. Management reiterated ambitious 2026 financing and asset sale targets while reporting quarterly results that beat expectations.
As European indices face headwinds, a select group of small-cap companies are seeing executives put their own money on the line. We examine three firms where insider buying signals conviction amidst broader uncertainty.
SL Green Realty Corp. posted a significant net loss for 2025 despite rising revenues and robust leasing activity. The Manhattan office landlord confirmed a shift to quarterly dividends and is advancing major financing and asset sale plans, placing cash conservation and balance sheet flexibility at the forefront of its recovery strategy.
As a profitable outlier in a battered sector, Ethos Technologies' successful IPO marks a pivotal test for investor appetite in 2026's tech listings, even as its debut valuation reflects a more sober market reality.
As Insmed prepares to unveil key data for its TPIP program at a major medical congress, fresh analyst coverage highlights the treatment's potential to reshape the company's future. Amidst a volatile stock performance, investors are weighing high-growth prospects against persistent financial risks.
While Medicare provides a crucial safety net at 65, significant gaps in coverage for dental, vision, and long-term care can lead to six-figure annual expenses. Proactive planning with HSAs, specialized insurance, and strategic budgeting is essential to protect retirement savings.
Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.
The FDA has issued a complete response letter for Aquestive Therapeutics' sublingual epinephrine film Anaphylm, citing concerns over packaging and user instructions. The company aims to address the issues and resubmit its application by the third quarter of this year.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
Amidst a resilient market backdrop, we spotlight three U.S. stocks trading significantly below their estimated intrinsic value, offering potential for investors willing to navigate current volatility.
The Bureau of Labor Statistics announced Monday that the highly anticipated January employment data will not be released as scheduled this Friday, citing disruptions from a partial federal government shutdown. The report will be published only after funding is restored.
In a revealing interview, former NFL quarterback Tim Tebow recounts how coach Bill Belichick asked him to decline a seven-figure endorsement deal—only to be cut days later. Yet, a decade on, Tebow expresses admiration, not bitterness, toward the legendary coach.
Amid tightening climate regulations, Southern States LLC launches a new line of high-voltage switching products that replace the potent greenhouse gas SF6 with a readily available blend of carbon dioxide and oxygen, promising a dramatic reduction in environmental impact without compromising grid reliability.
